Area of research
Physiology · Pharmacology · kuma · cancer · breast cancer drug design
Research interest
Research interests include Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Prostate Cancer Treatment and Research, and melanin and skin pigmentation.
Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins
Targeted Discovery of β‑Branched Conjugated Polyketides from Bacteria Based on Genomic and Metabolomic Hallmarks.
Quantitative Assessment of Particulate Matter Biodistribution Using
<sup>14</sup>
C-Nanotracing and Accelerator Mass Spectrometry
Decision tree model to predict one-year survival in ambulatory patients with advanced cancer.
Prognostic analysis according to adjuvant chemotherapy and anti-HER2 therapy following surgery in T1a/b HER2-positive breast cancer.
Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response
In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid-
<i>β</i>
Using Electromagnetic Waves
Charge Modification of Lysine Mitigates Amyloid‐β Aggregation
Tau Repeats Disassemble Amyloid-β Fibrils <i>In Vitro</i> by Interacting with KLVFFA and GGVVIA Domains
Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP).
Early onset diagnosis in Alzheimer's disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid.
Chemical-Driven Amyloid Clearance for Therapeutics and Diagnostics of Alzheimer’s Disease
Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers
Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease
Chemically Driven Clearance of Amyloid Aggregates by Polyfunctionalized Furo[2,3-<i>b</i>:4,5-<i>b</i>′]dipyridine–Chalcone Hybrids to Ameliorate Memory in an Alzheimer Mouse Model
Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers
Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques
Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
Benzo[<i>d</i>]imidazole-pyrrolo[1,2-<i>a</i>]pyrazine Hybrids Ameliorate Amyloid Aggregates in the Brain of Alzheimer Transgenic Mice
Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregation
Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β3-42 peptide
4-Acyl-3,4-dihydropyrrolo[1,2-<i>a</i>]pyrazine Derivative Rescued the Hippocampal-Dependent Cognitive Decline of 5XFAD Transgenic Mice by Dissociating Soluble and Insoluble Aβ Aggregates
Pioneering the Early Diagnosis of Alzheimer’s Disease: Aβ Oligomers-Sensing Probe for Cerebrospinal Fluid Analysis in Patients
Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques
Immobilized Amyloid Hexamer Fragments to Map Active Sites of Amyloid-Targeting Chemicals
Branched, dendritic, and hyperbranched polymers in liquid biopsy device design
Chemical‐Driven Outflow of Dissociated Amyloid Burden from Brain to Blood
Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response
Azetidine-Bearing Non-Ribosomal Peptides, Bonnevillamides D and E, Isolated from a Carrion Beetle-Associated Actinomycete
Azetidine-Bearing Non-Ribosomal Peptides, Bonnevillamides D and E, Isolated from a Carrion Beetle-Associated Actinomycete